Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)

INTRODUCTION: Although non-melanoma skin cancers (NMSCs) are associated with a very low mortality risk, they have been reported to have a major impact on patients’ health-related quality of life (HRQoL). Vismodegib is a therapy for patients who are affected by locally advanced basal cell carcinoma (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Dermatol Ther (Heidelb)
Main Authors: Villani, Alessia, Megna, Matteo, Fabbrocini, Gabriella, Cappello, Milena, Luciano, Maria Antonietta, Costa, Claudia, Scalvenzi, Massimiliano
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2019
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6828856/
https://ncbi.nlm.nih.gov/pubmed/31506916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-019-00323-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares